Antiemetics Market 2022-2028

Description

List of Tables

Global Antiemetics Market Size, Share & Trends Analysis Report by Drug Class (5-HT3 receptor antagonists, Anticholinergics, Benzodiazepines, Cannabinoids, and Others), and by Application (Chemotherapy, Gastroenteritis, General Anesthetics, Pregnancy, and Others) Forecast 2022-2028

The global antiemetics market is anticipated to grow at a substantial CAGR during the forecast period. The global antiemetics market is growing due to rising number of cancer patients and the raising number of surgeries. Manufacturers are exploiting nanotechnology in the antiemetics to deliver therapeutic agents to specific targeted sites in a controlled manner through Nano medicine and Nano delivery systems. Nano medicine is the medical application of nanotechnology which uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures and systems by controlled manipulation of size and shape at the nanometer scale. Such innovations are expected to offer lucrative opportunities to the market growth.

The global antiemetics market is segmented based on the drug class and application. Based on the drug class, the market is segmented into5-HT3 receptor antagonists, anticholinergics, benzodiazepines, cannabinoids, others. Based on the application, the market is sub-segmented into chemotherapy, gastroenteritis, general anesthetics, pregnancy, and others. The above-mentioned segments can be customized as per the requirements. Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America held considerable share in the market. The Asia-Pacific is the fastest increasing market due to the increasing cancer population, high incidence of gastroenteritis, and other diseases.

The major companies serving the global antiemetics market include GlaxoSmithKline plc, Merck KGaA, Eli Lilly and Co., Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers &acquisitions, collaborations, funding, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global antiemetics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Antiemetics Market Research and Analysis by Drug Class.

2. Global Antiemetics Market Research and Analysis by Application.

The Report Covers:

Comprehensive Research Methodology of the global antiemetics market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global antiemetics market.
Insights about market determinants that are stimulating the global antiemetics market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2025676

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on heGlobal Antiemetics Market
Recovery Scenario of Global Antiemetics Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. AstellasPharma Inc.
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Eli Lilly and Co.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. GlaxoSmithKline plc
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Merck KGaA
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Key Strategy Analysis
3.6. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Antiemetics Market by Drug Class
- 4.1.1. 5-HT3 receptor antagonists
- 4.1.2. Anticholinergics
- 4.1.3. Benzodiazepines
- 4.1.4. Cannabinoids
- 4.1.5. Others
4.2. Global Antiemetics Market by Application
- 4.2.1. Chemotherapy
- 4.2.2. Gastroenteritis
- 4.2.3. General anesthetics
- 4.2.4. Pregnancy
- 4.2.5. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. AbbottLaboratories
6.2. BaxterInternational Inc.
6.3. Bristol Myers Squibb
6.4. Cipla Ltd.
6.5. IPCA Labs
6.6. Johnson & Johnson
6.7. Novartis AG
6.8. Pfizer
6.9. Reddy Laboratories Ltd.
6.10. Sanofi SA

*List not Exhaustive**